Company news

Argenica Therapeutics Ltd news in 2021

Argenica Therapeutics Ltd's news releases, calls and decks from 2021, newest first.

View company

Argenica to be Granted Patent Protection in the US

December 8, 2021

Positive Preclinical Data for ARG-007 Neuroprotection in HIE

November 2, 2021

Phase 1 Clinical Trial Overview & Roadmap

October 17, 2021

Argenica Partners With Linear For Phase 1 Clinical Trial

September 30, 2021

Argenica Achieves Manufacturing Milestones

September 13, 2021

Appendix 4E & Annual Report 30 June 2021

August 26, 2021

Grant Secured to Advance Pre-Clinical Studies Of ARG-007

July 20, 2021

Study Additional Information

July 13, 2021

Study Shows ARG-007 Does Not Degrade

July 12, 2021

Argenica Completes Pilot Pre-Clinical Pharmacokinetics Study

July 1, 2021

Decks in 2021